市場調査レポート

商品コード

1446908

シクロデキストリン市場：タイプ別、エンドユーザー産業別：世界の機会分析と産業予測、2023年～2032年

Cyclodextrin Market By Type (Alpha-Cyclodextrin, Beta-Cyclodextrin, Gamma-Cyclodextrin), By End-User Industry (Food, Pharmaceutical, Cosmetics and Personal Care, Chemical, Textile, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日: 2024年01月30日
発行: Allied Market Research
ページ情報: 英文 354 Pages
納期: 2～3営業日

価格

PDF (Business License)

USD 5,730 842,252円

レポートPDFを1名がご利用いただけるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は5回まで可能です。 2名以上でご利用の場合、追加料金を支払う事によりユーザーを最大５名まで追加する事が可能です。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,411,104円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のシクロデキストリン市場は、2022年に3億3,400万米ドルと評価され、2023年から2032年にかけて5.7%のCAGRを示し、2032年には5億7,960万米ドルに達すると推定されています。

シクロデキストリンは、α-1,4-グリコシド結合で結ばれたグルコース単位からなる環状オリゴ糖です。これらの分子は、疎水性の中心空洞と親水性の外表面を特徴とする、ユニークなトーラスまたは切り詰められた円錐構造を持っています。シクロデキストリンは、他の分子と包接複合体を形成する能力で知られており、ゲスト分子はその中心空洞内に封入することができます。この特性により、シクロデキストリンは医薬品、食品、化粧品など様々な産業において、様々な化合物の溶解性、安定性、生物学的利用能の向上などの用途に有用です。

持続可能性とグリーンケミストリーの実践が重視されるようになっていることも、シクロデキストリン市場の推進力となっています。シクロデキストリンは生分解性で環境に優しいため、環境に優しい代替物質が優先される用途には魅力的です。従来の化学物質の代わりにシクロデキストリンを使用することは、持続可能な慣行への世界の後押しと一致し、環境に配慮したソリューションを求める産業にアピールします。

さらに、さまざまな産業で研究開発が進められていることも、シクロデキストリン市場の拡大に寄与しています。研究者たちは、シクロデキストリンのユニークな特性を活用した新しい用途や配合を模索しています。これには、新規ドラッグデリバリーシステム、カプセル化技術の改良、農業や繊維製品などの分野における革新的な用途が含まれます。新規用途の絶え間ない発見と独自の製剤開発が、シクロデキストリンの需要を牽引しています。

しかし、規制上の考慮事項もシクロデキストリン市場に影響を与えています。シクロデキストリンは医薬品や食品を含む様々な用途に使用されるため、厳格な規制要件の遵守は極めて重要です。シクロデキストリン含有製品の規制当局の承認取得には時間とコストがかかります。さらに、規制状況の変化やコンプライアンス基準の変更により、メーカーは継続的な適応が必要となり、市場に複雑なレイヤーを追加する可能性があります。

一方、飲食品分野では、シクロデキストリンはカプセル化剤、風味改良剤、安定剤として応用されています。シクロデキストリンは製品の品質、味、保存性の向上に貢献しています。消費者がより健康的で自然な食材を求める傾向が強まる中、好ましくない風味や臭いをマスキングする機能を持つサイクロデキストリンは、食品メーカーにとって貴重な存在となっています。クリーンラベル製品への動向と機能性食品への需要が、この市場セグメントの機会をさらに促進しています。

シクロデキストリン市場は、タイプ、エンドユーザー産業、地域によって区分されます。タイプ別では、市場はアルファ-シクロデキストリン、ベータ-シクロデキストリン、ガンマ-シクロデキストリンに分類されます。エンドユーザー産業ベースでは、食品、医薬品、化粧品＆パーソナルケア、化学、繊維、その他に分けられます。地域別では、市場は北米、欧州、アジア太平洋、LAMEAで調査されます。

利害関係者にとっての主なメリット

当レポートでは、2022年から2032年までのシクロデキストリン市場分析の市場セグメント、現在の動向、推定・動向、力学を定量的に分析し、有力なシクロデキストリン市場機会を特定します。
市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を提供します。
ポーターのファイブフォース分析では、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるよう、バイヤーとサプライヤーの潜在力を明らかにします。
シクロデキストリン市場のセグメンテーションの詳細な分析は、市場機会を決定するのに役立ちます。
各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
本レポートには、地域別および世界のシクロデキストリン市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析が含まれています。

本レポートで可能なカスタマイズ（追加費用とスケジュールがあります。）

製造能力
投資機会
サプライチェーン分析とベンダーのマージン
技術動向分析
製品/セグメント別企業の市場セグメンテーション分析
主要企業の新製品開発/製品マトリックス
国、地域、世界レベルでの患者/疫学データ
規制ガイドライン
顧客の関心に応じた追加の企業プロファイル
国別または地域別の追加分析-市場規模と予測
企業プロファイルの拡張リスト
過去の市場データ
輸出入分析/データ
主要企業の詳細（所在地、連絡先、サプライヤー/ベンダーネットワークなどを含む、エクセル形式）
世界/地域/国別レベルでのプレーヤーの市場シェア分析
SWOT分析
数量市場規模と予測

概要
北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- その他
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- オーストラリア
- その他
ラテンアメリカ・中東・アフリカ
- ブラジル
- サウジアラビア
- 南アフリカ
- その他

第7章競合情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合ヒートマップ
主要企業のポジショニング、2022年

第8章企業プロファイル

Cayman Chemical Company
Cambrex Corporation
Wellona Pharma Private Limited.
Wacker Chemie AG.
Cyclolab
Tocopharm Co. Limited
Roquette Freres
Midas Pharma GmbH
Ligand Pharmaceuticals Incorporated
Cyclo Therapeutics, Inc

図表

LIST OF TABLES

TABLE 01. GLOBAL CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 02. GLOBAL CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 03. CYCLODEXTRIN MARKET FOR ALPHA-CYCLODEXTRIN, BY REGION, 2022-2032 ($MILLION)
TABLE 04. CYCLODEXTRIN MARKET FOR ALPHA-CYCLODEXTRIN, BY REGION, 2022-2032 (TONS)
TABLE 05. CYCLODEXTRIN MARKET FOR BETA-CYCLODEXTRIN, BY REGION, 2022-2032 ($MILLION)
TABLE 06. CYCLODEXTRIN MARKET FOR BETA-CYCLODEXTRIN, BY REGION, 2022-2032 (TONS)
TABLE 07. CYCLODEXTRIN MARKET FOR GAMMA-CYCLODEXTRIN, BY REGION, 2022-2032 ($MILLION)
TABLE 08. CYCLODEXTRIN MARKET FOR GAMMA-CYCLODEXTRIN, BY REGION, 2022-2032 (TONS)
TABLE 09. GLOBAL CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 10. GLOBAL CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 11. CYCLODEXTRIN MARKET FOR FOOD, BY REGION, 2022-2032 ($MILLION)
TABLE 12. CYCLODEXTRIN MARKET FOR FOOD, BY REGION, 2022-2032 (TONS)
TABLE 13. CYCLODEXTRIN MARKET FOR PHARMACEUTICAL, BY REGION, 2022-2032 ($MILLION)
TABLE 14. CYCLODEXTRIN MARKET FOR PHARMACEUTICAL, BY REGION, 2022-2032 (TONS)
TABLE 15. CYCLODEXTRIN MARKET FOR COSMETICS AND PERSONAL CARE, BY REGION, 2022-2032 ($MILLION)
TABLE 16. CYCLODEXTRIN MARKET FOR COSMETICS AND PERSONAL CARE, BY REGION, 2022-2032 (TONS)
TABLE 17. CYCLODEXTRIN MARKET FOR CHEMICAL, BY REGION, 2022-2032 ($MILLION)
TABLE 18. CYCLODEXTRIN MARKET FOR CHEMICAL, BY REGION, 2022-2032 (TONS)
TABLE 19. CYCLODEXTRIN MARKET FOR TEXTILE, BY REGION, 2022-2032 ($MILLION)
TABLE 20. CYCLODEXTRIN MARKET FOR TEXTILE, BY REGION, 2022-2032 (TONS)
TABLE 21. CYCLODEXTRIN MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 22. CYCLODEXTRIN MARKET FOR OTHERS, BY REGION, 2022-2032 (TONS)
TABLE 23. CYCLODEXTRIN MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 24. CYCLODEXTRIN MARKET, BY REGION, 2022-2032 (TONS)
TABLE 25. NORTH AMERICA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 26. NORTH AMERICA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 27. NORTH AMERICA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 28. NORTH AMERICA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 29. NORTH AMERICA CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 30. NORTH AMERICA CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 (TONS)
TABLE 31. U.S. CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 32. U.S. CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 33. U.S. CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 34. U.S. CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 35. CANADA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 36. CANADA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 37. CANADA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 38. CANADA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 39. MEXICO CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 40. MEXICO CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 41. MEXICO CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 42. MEXICO CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 43. EUROPE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 44. EUROPE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 45. EUROPE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 46. EUROPE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 47. EUROPE CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 48. EUROPE CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 (TONS)
TABLE 49. GERMANY CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 50. GERMANY CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 51. GERMANY CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 52. GERMANY CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 53. UK CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 54. UK CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 55. UK CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 56. UK CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 57. FRANCE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 58. FRANCE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 59. FRANCE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 60. FRANCE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 61. SPAIN CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 62. SPAIN CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 63. SPAIN CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 64. SPAIN CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 65. ITALY CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 66. ITALY CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 67. ITALY CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 68. ITALY CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 69. REST OF EUROPE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 70. REST OF EUROPE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 71. REST OF EUROPE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 72. REST OF EUROPE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 73. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 74. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 75. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 76. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 77. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 78. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 (TONS)
TABLE 79. CHINA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 80. CHINA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 81. CHINA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 82. CHINA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 83. INDIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 84. INDIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 85. INDIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 86. INDIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 87. JAPAN CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 88. JAPAN CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 89. JAPAN CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 90. JAPAN CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 91. SOUTH KOREA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 92. SOUTH KOREA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 93. SOUTH KOREA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 94. SOUTH KOREA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 95. AUSTRALIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 96. AUSTRALIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 97. AUSTRALIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 98. AUSTRALIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 99. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 100. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 101. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 102. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 103. LAMEA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 104. LAMEA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 105. LAMEA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 106. LAMEA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 107. LAMEA CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 108. LAMEA CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 (TONS)
TABLE 109. BRAZIL CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 110. BRAZIL CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 111. BRAZIL CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 112. BRAZIL CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 113. SAUDI ARABIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 114. SAUDI ARABIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 115. SAUDI ARABIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 116. SAUDI ARABIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 117. SOUTH AFRICA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 118. SOUTH AFRICA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 119. SOUTH AFRICA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 120. SOUTH AFRICA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 121. REST OF LAMEA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 122. REST OF LAMEA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
TABLE 123. REST OF LAMEA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
TABLE 124. REST OF LAMEA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
TABLE 125. CAYMAN CHEMICAL COMPANY: KEY EXECUTIVES
TABLE 126. CAYMAN CHEMICAL COMPANY: COMPANY SNAPSHOT
TABLE 127. CAYMAN CHEMICAL COMPANY: PRODUCT SEGMENTS
TABLE 128. CAYMAN CHEMICAL COMPANY: SERVICE SEGMENTS
TABLE 129. CAYMAN CHEMICAL COMPANY: PRODUCT PORTFOLIO
TABLE 130. CAYMAN CHEMICAL COMPANY: KEY STRATERGIES
TABLE 131. CAMBREX CORPORATION: KEY EXECUTIVES
TABLE 132. CAMBREX CORPORATION: COMPANY SNAPSHOT
TABLE 133. CAMBREX CORPORATION: PRODUCT SEGMENTS
TABLE 134. CAMBREX CORPORATION: SERVICE SEGMENTS
TABLE 135. CAMBREX CORPORATION: PRODUCT PORTFOLIO
TABLE 136. CAMBREX CORPORATION: KEY STRATERGIES
TABLE 137. WELLONA PHARMA PRIVATE LIMITED.: KEY EXECUTIVES
TABLE 138. WELLONA PHARMA PRIVATE LIMITED.: COMPANY SNAPSHOT
TABLE 139. WELLONA PHARMA PRIVATE LIMITED.: PRODUCT SEGMENTS
TABLE 140. WELLONA PHARMA PRIVATE LIMITED.: SERVICE SEGMENTS
TABLE 141. WELLONA PHARMA PRIVATE LIMITED.: PRODUCT PORTFOLIO
TABLE 142. WELLONA PHARMA PRIVATE LIMITED.: KEY STRATERGIES
TABLE 143. WACKER CHEMIE AG.: KEY EXECUTIVES
TABLE 144. WACKER CHEMIE AG.: COMPANY SNAPSHOT
TABLE 145. WACKER CHEMIE AG.: PRODUCT SEGMENTS
TABLE 146. WACKER CHEMIE AG.: SERVICE SEGMENTS
TABLE 147. WACKER CHEMIE AG.: PRODUCT PORTFOLIO
TABLE 148. WACKER CHEMIE AG.: KEY STRATERGIES
TABLE 149. CYCLOLAB: KEY EXECUTIVES
TABLE 150. CYCLOLAB: COMPANY SNAPSHOT
TABLE 151. CYCLOLAB: PRODUCT SEGMENTS
TABLE 152. CYCLOLAB: SERVICE SEGMENTS
TABLE 153. CYCLOLAB: PRODUCT PORTFOLIO
TABLE 154. CYCLOLAB: KEY STRATERGIES
TABLE 155. TOCOPHARM CO. LIMITED: KEY EXECUTIVES
TABLE 156. TOCOPHARM CO. LIMITED: COMPANY SNAPSHOT
TABLE 157. TOCOPHARM CO. LIMITED: PRODUCT SEGMENTS
TABLE 158. TOCOPHARM CO. LIMITED: SERVICE SEGMENTS
TABLE 159. TOCOPHARM CO. LIMITED: PRODUCT PORTFOLIO
TABLE 160. TOCOPHARM CO. LIMITED: KEY STRATERGIES
TABLE 161. ROQUETTE FRERES: KEY EXECUTIVES
TABLE 162. ROQUETTE FRERES: COMPANY SNAPSHOT
TABLE 163. ROQUETTE FRERES: PRODUCT SEGMENTS
TABLE 164. ROQUETTE FRERES: SERVICE SEGMENTS
TABLE 165. ROQUETTE FRERES: PRODUCT PORTFOLIO
TABLE 166. ROQUETTE FRERES: KEY STRATERGIES
TABLE 167. MIDAS PHARMA GMBH: KEY EXECUTIVES
TABLE 168. MIDAS PHARMA GMBH: COMPANY SNAPSHOT
TABLE 169. MIDAS PHARMA GMBH: PRODUCT SEGMENTS
TABLE 170. MIDAS PHARMA GMBH: SERVICE SEGMENTS
TABLE 171. MIDAS PHARMA GMBH: PRODUCT PORTFOLIO
TABLE 172. MIDAS PHARMA GMBH: KEY STRATERGIES
TABLE 173. LIGAND PHARMACEUTICALS INCORPORATED: KEY EXECUTIVES
TABLE 174. LIGAND PHARMACEUTICALS INCORPORATED: COMPANY SNAPSHOT
TABLE 175. LIGAND PHARMACEUTICALS INCORPORATED: PRODUCT SEGMENTS
TABLE 176. LIGAND PHARMACEUTICALS INCORPORATED: SERVICE SEGMENTS
TABLE 177. LIGAND PHARMACEUTICALS INCORPORATED: PRODUCT PORTFOLIO
TABLE 178. LIGAND PHARMACEUTICALS INCORPORATED: KEY STRATERGIES
TABLE 179. CYCLO THERAPEUTICS, INC: KEY EXECUTIVES
TABLE 180. CYCLO THERAPEUTICS, INC: COMPANY SNAPSHOT
TABLE 181. CYCLO THERAPEUTICS, INC: PRODUCT SEGMENTS
TABLE 182. CYCLO THERAPEUTICS, INC: SERVICE SEGMENTS
TABLE 183. CYCLO THERAPEUTICS, INC: PRODUCT PORTFOLIO
TABLE 184. CYCLO THERAPEUTICS, INC: KEY STRATERGIES

LIST OF FIGURES

FIGURE 01. CYCLODEXTRIN MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF CYCLODEXTRIN MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN CYCLODEXTRIN MARKET
FIGURE 04. TOP INVESTMENT POCKETS IN CYCLODEXTRIN MARKET (2023-2032)
FIGURE 05. BARGAINING POWER OF SUPPLIERS
FIGURE 06. BARGAINING POWER OF BUYERS
FIGURE 07. THREAT OF SUBSTITUTION
FIGURE 08. THREAT OF SUBSTITUTION
FIGURE 09. COMPETITIVE RIVALRY
FIGURE 10. GLOBAL CYCLODEXTRIN MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. PRICING ANALYSIS: CYCLODEXTRIN MARKET 2022 AND 2032
FIGURE 12. IMPACT OF KEY REGULATION: CYCLODEXTRIN MARKET
FIGURE 13. PATENT ANALYSIS BY COMPANY
FIGURE 14. PATENT ANALYSIS BY COUNTRY
FIGURE 15. CYCLODEXTRIN MARKET, BY TYPE, 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR ALPHA-CYCLODEXTRIN, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR BETA-CYCLODEXTRIN, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR GAMMA-CYCLODEXTRIN, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022 AND 2032(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR FOOD, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR PHARMACEUTICAL, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR COSMETICS AND PERSONAL CARE, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR CHEMICAL, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR TEXTILE, BY COUNTRY 2022 AND 2032(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 26. CYCLODEXTRIN MARKET BY REGION, 2022 AND 2032(%)
FIGURE 27. U.S. CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 28. CANADA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 29. MEXICO CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 30. GERMANY CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 31. UK CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 32. FRANCE CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 33. SPAIN CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 34. ITALY CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 35. REST OF EUROPE CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 36. CHINA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 37. INDIA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 38. JAPAN CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 39. SOUTH KOREA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 40. AUSTRALIA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 41. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 42. BRAZIL CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 43. SAUDI ARABIA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 44. SOUTH AFRICA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 45. REST OF LAMEA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 50. COMPETITIVE DASHBOARD
FIGURE 51. COMPETITIVE HEATMAP: CYCLODEXTRIN MARKET
FIGURE 52. TOP PLAYER POSITIONING, 2022

Product Code: A107969

The global cyclodextrin market was valued at $334.0 million in 2022 and is estimated to reach $579.6 million by 2032, exhibiting a CAGR of 5.7% from 2023 to 2032.

Cyclodextrins are cyclic oligosaccharides composed of glucose units linked by alpha-1,4-glycosidic bonds. These molecules have a unique torus or truncated cone structure, characterized by a hydrophobic central cavity and a hydrophilic outer surface. Cyclodextrins are known for their ability to form inclusion complexes with other molecules, where the guest molecule can be encapsulated within their central cavity. This property makes cyclodextrins useful in various industries, including pharmaceuticals, food, cosmetics, and more, for applications such as improving the solubility, stability, and bioavailability of different compounds.

The growing emphasis on sustainability and green chemistry practices is another driving force for the cyclodextrin market. Cyclodextrins are biodegradable and environmentally friendly, making them attractive for applications where eco-friendly alternatives are prioritized. The use of cyclodextrins in place of traditional chemicals aligns with the global push towards sustainable practices, appealing to industries seeking environmentally conscious solutions.

Moreover, ongoing research and development activities in various industries contribute to the expansion of the cyclodextrin market. Researchers are exploring new applications and formulations that leverage the unique properties of cyclodextrins. This includes novel drug delivery systems, improved encapsulation techniques, and innovative uses in areas such as agriculture and textiles. The continuous discovery of novel applications and the development of proprietary formulations drive the demand for cyclodextrins.

However, regulatory considerations also impact the cyclodextrin market. As cyclodextrins are used in various applications, including pharmaceuticals and food products, adherence to stringent regulatory requirements is crucial. Obtaining regulatory approvals for cyclodextrin-containing products can be time-consuming and expensive. Additionally, evolving regulatory landscapes and changes in compliance standards may require continuous adaptation by manufacturers, adding a layer of complexity to the market.

On the contrary, in the food and beverage sector, cyclodextrins find applications as encapsulating agents, flavor modifiers, and stabilizers. They contribute to improved product quality, taste, and shelf life. As consumers increasingly seek healthier and more natural ingredients, cyclodextrins, with their ability to mask undesirable flavors and odors, become invaluable for food manufacturers. The trend towards clean-label products and the demand for functional foods further drive the opportunities in this market segment.

The cyclodextrin market is segmented on the basis of type, end-user industry, and region. On the basis of type, the market is categorized into alpha-cyclodextrin, beta-cyclodextrin, and gamma-cyclodextrin. On the basis of end-user industry, it is divided into food, pharmaceutical, cosmetics & personal care, chemical, textile, and others. Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

The global cyclodextrin market profiles leading players that include Cambrex Corporation, Cayman Chemical, Wellona Pharma, Wacker Chemie AG, Cyclolab, Tocopharm Co. Limited, Roquette Freres, Midas Pharma GmbH, Ligand Pharmaceuticals Incorporated, and Cyclo Therapeutics, Inc.

Other key players involved in the manufacturing of cyclodextrin includes Zibo Qianhui biological technology co., ltd, Xi'an Deli Biochemical Industry Co., Ltd, Merck KgaA, Otto Chemie Pvt. Ltd., VIO CHEMICALS, Ashland, and TCI Chemicals Pvt. Ltd. The global cyclodextrin market report provides in-depth competitive analysis as well as profiles of these major players.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cyclodextrin market analysis from 2022 to 2032 to identify the prevailing cyclodextrin market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the cyclodextrin market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global cyclodextrin market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Manufacturing Capacity
Investment Opportunities
Supply Chain Analysis & Vendor Margins
Technology Trend Analysis
Market share analysis of players by products/segments
New Product Development/ Product Matrix of Key Players
Patient/epidemiology data at country, region, global level
Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Import Export Analysis/Data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Market share analysis of players at global/region/country level
SWOT Analysis
Volume Market Size and Forecast

Key Market Segments

By Type

Alpha-Cyclodextrin
Beta-Cyclodextrin
Gamma-Cyclodextrin

By End-User Industry

Food
Pharmaceutical
Cosmetics and Personal Care
Chemical
Textile
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Cayman Chemical Company
Cambrex Corporation
Wellona Pharma Private Limited.
Wacker Chemie AG.
Cyclolab
Tocopharm Co. Limited
Roquette Freres
Midas Pharma GmbH
Ligand Pharmaceuticals Incorporated
Cyclo Therapeutics, Inc

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
3.5. Value Chain Analysis
3.6. Pricing Analysis
3.7. Key Regulation Analysis
3.8. Patent Landscape

CHAPTER 4: CYCLODEXTRIN MARKET, BY TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Alpha-Cyclodextrin
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Beta-Cyclodextrin
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Gamma-Cyclodextrin
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country

CHAPTER 5: CYCLODEXTRIN MARKET, BY END-USER INDUSTRY

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Food
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Pharmaceutical
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Cosmetics and Personal Care
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Chemical
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country
5.6. Textile
- 5.6.1. Key market trends, growth factors and opportunities
- 5.6.2. Market size and forecast, by region
- 5.6.3. Market share analysis by country
5.7. Others
- 5.7.1. Key market trends, growth factors and opportunities
- 5.7.2. Market size and forecast, by region
- 5.7.3. Market share analysis by country

CHAPTER 6: CYCLODEXTRIN MARKET, BY REGION

6.1. Overview
- 6.1.1. Market size and forecast By Region
6.2. North America
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by Type
- 6.2.3. Market size and forecast, by End-User Industry
- 6.2.4. Market size and forecast, by country
  - 6.2.4.1. U.S.
  - 6.2.4.1.1. Market size and forecast, by Type
  - 6.2.4.1.2. Market size and forecast, by End-User Industry
  - 6.2.4.2. Canada
  - 6.2.4.2.1. Market size and forecast, by Type
  - 6.2.4.2.2. Market size and forecast, by End-User Industry
  - 6.2.4.3. Mexico
  - 6.2.4.3.1. Market size and forecast, by Type
  - 6.2.4.3.2. Market size and forecast, by End-User Industry
6.3. Europe
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by Type
- 6.3.3. Market size and forecast, by End-User Industry
- 6.3.4. Market size and forecast, by country
  - 6.3.4.1. Germany
  - 6.3.4.1.1. Market size and forecast, by Type
  - 6.3.4.1.2. Market size and forecast, by End-User Industry
  - 6.3.4.2. UK
  - 6.3.4.2.1. Market size and forecast, by Type
  - 6.3.4.2.2. Market size and forecast, by End-User Industry
  - 6.3.4.3. France
  - 6.3.4.3.1. Market size and forecast, by Type
  - 6.3.4.3.2. Market size and forecast, by End-User Industry
  - 6.3.4.4. Spain
  - 6.3.4.4.1. Market size and forecast, by Type
  - 6.3.4.4.2. Market size and forecast, by End-User Industry
  - 6.3.4.5. Italy
  - 6.3.4.5.1. Market size and forecast, by Type
  - 6.3.4.5.2. Market size and forecast, by End-User Industry
  - 6.3.4.6. Rest of Europe
  - 6.3.4.6.1. Market size and forecast, by Type
  - 6.3.4.6.2. Market size and forecast, by End-User Industry
6.4. Asia-Pacific
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by Type
- 6.4.3. Market size and forecast, by End-User Industry
- 6.4.4. Market size and forecast, by country
  - 6.4.4.1. China
  - 6.4.4.1.1. Market size and forecast, by Type
  - 6.4.4.1.2. Market size and forecast, by End-User Industry
  - 6.4.4.2. India
  - 6.4.4.2.1. Market size and forecast, by Type
  - 6.4.4.2.2. Market size and forecast, by End-User Industry
  - 6.4.4.3. Japan
  - 6.4.4.3.1. Market size and forecast, by Type
  - 6.4.4.3.2. Market size and forecast, by End-User Industry
  - 6.4.4.4. South Korea
  - 6.4.4.4.1. Market size and forecast, by Type
  - 6.4.4.4.2. Market size and forecast, by End-User Industry
  - 6.4.4.5. Australia
  - 6.4.4.5.1. Market size and forecast, by Type
  - 6.4.4.5.2. Market size and forecast, by End-User Industry
  - 6.4.4.6. Rest of Asia-Pacific
  - 6.4.4.6.1. Market size and forecast, by Type
  - 6.4.4.6.2. Market size and forecast, by End-User Industry
6.5. LAMEA
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by Type
- 6.5.3. Market size and forecast, by End-User Industry
- 6.5.4. Market size and forecast, by country
  - 6.5.4.1. Brazil
  - 6.5.4.1.1. Market size and forecast, by Type
  - 6.5.4.1.2. Market size and forecast, by End-User Industry
  - 6.5.4.2. Saudi Arabia
  - 6.5.4.2.1. Market size and forecast, by Type
  - 6.5.4.2.2. Market size and forecast, by End-User Industry
  - 6.5.4.3. South Africa
  - 6.5.4.3.1. Market size and forecast, by Type
  - 6.5.4.3.2. Market size and forecast, by End-User Industry
  - 6.5.4.4. Rest of LAMEA
  - 6.5.4.4.1. Market size and forecast, by Type
  - 6.5.4.4.2. Market size and forecast, by End-User Industry

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top winning strategies
7.3. Product mapping of top 10 player
7.4. Competitive dashboard
7.5. Competitive heatmap
7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

8.1. Cayman Chemical Company
- 8.1.1. Company overview
- 8.1.2. Key executives
- 8.1.3. Company snapshot
- 8.1.4. Operating business segments
- 8.1.5. Product portfolio
- 8.1.6. Business performance
- 8.1.7. Key strategic moves and developments
8.2. Cambrex Corporation
- 8.2.1. Company overview
- 8.2.2. Key executives
- 8.2.3. Company snapshot
- 8.2.4. Operating business segments
- 8.2.5. Product portfolio
- 8.2.6. Business performance
- 8.2.7. Key strategic moves and developments
8.3. Wellona Pharma Private Limited.
- 8.3.1. Company overview
- 8.3.2. Key executives
- 8.3.3. Company snapshot
- 8.3.4. Operating business segments
- 8.3.5. Product portfolio
- 8.3.6. Business performance
- 8.3.7. Key strategic moves and developments
8.4. Wacker Chemie AG.
- 8.4.1. Company overview
- 8.4.2. Key executives
- 8.4.3. Company snapshot
- 8.4.4. Operating business segments
- 8.4.5. Product portfolio
- 8.4.6. Business performance
- 8.4.7. Key strategic moves and developments
8.5. Cyclolab
- 8.5.1. Company overview
- 8.5.2. Key executives
- 8.5.3. Company snapshot
- 8.5.4. Operating business segments
- 8.5.5. Product portfolio
- 8.5.6. Business performance
- 8.5.7. Key strategic moves and developments
8.6. Tocopharm Co. Limited
- 8.6.1. Company overview
- 8.6.2. Key executives
- 8.6.3. Company snapshot
- 8.6.4. Operating business segments
- 8.6.5. Product portfolio
- 8.6.6. Business performance
- 8.6.7. Key strategic moves and developments
8.7. Roquette Freres
- 8.7.1. Company overview
- 8.7.2. Key executives
- 8.7.3. Company snapshot
- 8.7.4. Operating business segments
- 8.7.5. Product portfolio
- 8.7.6. Business performance
- 8.7.7. Key strategic moves and developments
8.8. Midas Pharma GmbH
- 8.8.1. Company overview
- 8.8.2. Key executives
- 8.8.3. Company snapshot
- 8.8.4. Operating business segments
- 8.8.5. Product portfolio
- 8.8.6. Business performance
- 8.8.7. Key strategic moves and developments
8.9. Ligand Pharmaceuticals Incorporated
- 8.9.1. Company overview
- 8.9.2. Key executives
- 8.9.3. Company snapshot
- 8.9.4. Operating business segments
- 8.9.5. Product portfolio
- 8.9.6. Business performance
- 8.9.7. Key strategic moves and developments
8.10. Cyclo Therapeutics, Inc
- 8.10.1. Company overview
- 8.10.2. Key executives
- 8.10.3. Company snapshot
- 8.10.4. Operating business segments
- 8.10.5. Product portfolio
- 8.10.6. Business performance
- 8.10.7. Key strategic moves and developments

シクロデキストリン市場：タイプ別、エンドユーザー産業別：世界の機会分析と産業予測、2023年～2032年

Cyclodextrin Market By Type (Alpha-Cyclodextrin, Beta-Cyclodextrin, Gamma-Cyclodextrin), By End-User Industry (Food, Pharmaceutical, Cosmetics and Personal Care, Chemical, Textile, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

利害関係者にとっての主なメリット

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章シクロデキストリン市場：タイプ別

第5章シクロデキストリン市場：エンドユーザー産業別

第6章シクロデキストリン市場：地域別

第7章競合情勢

第8章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By Type

By End-User Industry

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: CYCLODEXTRIN MARKET, BY TYPE

CHAPTER 5: CYCLODEXTRIN MARKET, BY END-USER INDUSTRY

CHAPTER 6: CYCLODEXTRIN MARKET, BY REGION

CHAPTER 7: COMPETITIVE LANDSCAPE

CHAPTER 8: COMPANY PROFILES

シクロデキストリン市場：タイプ別、エンドユーザー産業別：世界の機会分析と産業予測、2023年～2032年

Cyclodextrin Market By Type (Alpha-Cyclodextrin, Beta-Cyclodextrin, Gamma-Cyclodextrin), By End-User Industry (Food, Pharmaceutical, Cosmetics and Personal Care, Chemical, Textile, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

利害関係者にとっての主なメリット

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

第4章 シクロデキストリン市場：タイプ別

第5章 シクロデキストリン市場：エンドユーザー産業別

第6章 シクロデキストリン市場：地域別

第7章 競合情勢

第8章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By Type

By End-User Industry

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: CYCLODEXTRIN MARKET, BY TYPE

CHAPTER 5: CYCLODEXTRIN MARKET, BY END-USER INDUSTRY

CHAPTER 6: CYCLODEXTRIN MARKET, BY REGION

CHAPTER 7: COMPETITIVE LANDSCAPE

CHAPTER 8: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章シクロデキストリン市場：タイプ別

第5章シクロデキストリン市場：エンドユーザー産業別

第6章シクロデキストリン市場：地域別

第7章競合情勢

第8章企業プロファイル